Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis.

MLA

Bartsch, Yannic C., et al. “Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis.” Frontiers in Immunology, June 2018, pp. 1–16. EBSCOhost, https://doi.org/10.3389/fimmu.2018.01183.

APA

Bartsch, Y. C., Rahmöller, J., Mertes, M. M. M., Eiglmeier, S., Lorenz, F. K. M., Stoehr, A. D., Braumann, D., Lorenz, A. K., Winkler, A., Lilienthal, G.-M., Petry, J., Hobusch, J., Steinhaus, M., Hess, C., Holecska, V., Schoen, C. T., Oefner, C. M., Leliavski, A., Blanchard, V., & Ehlers, M. (2018). Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis. Frontiers in Immunology, 1–16. https://doi.org/10.3389/fimmu.2018.01183

Chicago

Bartsch, Yannic C., Johann Rahmöller, Maria M. M. Mertes, Susanne Eiglmeier, Felix K. M. Lorenz, Alexander D. Stoehr, Dominique Braumann, et al. 2018. “Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis.” Frontiers in Immunology, June, 1–16. doi:10.3389/fimmu.2018.01183.